Search research articles
Contact Us
Filters
Showing results (31-40 of 126) with videos related to
Page
of 13
Sort By:
The Medical Clinics of North America
|
September 1, 1977
Specific immunotherapy with neuraminidase-modified leukemic cells: experimental and clinical trials
J G Bekesi, J F Holland, J P Roboz
Annals of the New York Academy of Sciences
|
January 1, 1976
Therapeutic effectiveness of neuraminidase-treated tumor cells as an immunogen in man and experimental animals with leukemia
J G Bekesi, J P Roboz, J F Holland
Israel Journal of Medical Sciences
|
April 1, 1976
Characteristics of immunity induced by neuraminidase-treated lymphosarcoma cells in C3H (MTV+) and C3H (MTV-) mice
J G Bekesi, J P Roboz, J F Holland
Journal of Clinical & Laboratory Immunology
|
December 1, 1982
Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer
P H Tsang, J F Holland, J G Bekesi
Journal of Virology
|
April 1, 1980
Alterations of a mouse mammary tumor virus glycoprotein with interferon treatment
M J Yagi, N W King, J G Bekesi
Journal of Clinical & Laboratory Immunology
|
November 1, 1987
Tumor necrosis factor enhances murine SL3-3 retrovirus replication
M J Yagi, J F Holland, J G Bekesi
Cancer Research
|
December 1, 1971
Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment
J G Bekesi, G St-Arneault, J F Holland
Blood
|
January 1, 1985
B cell differentiation
A P Efremidis, J G Bekesi, M S Vessoniaraki
Bibliotheca Haematologica
|
October 1, 1975
Chemoimmunotherapy in human and experimental leukemia
J G Bekesi, J P Roboz, J F Holland
Cellular Immunology
|
November 1, 1982
Central role of T lymphocytes in specific recognition of tumor antigens in 51Cr-leukocyte adherence inhibition
P H Tsang, J F Holland, J G Bekesi
Page
of 13
Search research articles
Search
Showing results (31-40 of 126) with videos related to
Sort By:
Page
of 13
The Medical Clinics of North America
|
September 1, 1977
Specific immunotherapy with neuraminidase-modified leukemic cells: experimental and clinical trials
J G Bekesi, J F Holland, J P Roboz
Annals of the New York Academy of Sciences
|
January 1, 1976
Therapeutic effectiveness of neuraminidase-treated tumor cells as an immunogen in man and experimental animals with leukemia
J G Bekesi, J P Roboz, J F Holland
Israel Journal of Medical Sciences
|
April 1, 1976
Characteristics of immunity induced by neuraminidase-treated lymphosarcoma cells in C3H (MTV+) and C3H (MTV-) mice
J G Bekesi, J P Roboz, J F Holland
Journal of Clinical & Laboratory Immunology
|
December 1, 1982
Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer
P H Tsang, J F Holland, J G Bekesi
Journal of Virology
|
April 1, 1980
Alterations of a mouse mammary tumor virus glycoprotein with interferon treatment
M J Yagi, N W King, J G Bekesi
Journal of Clinical & Laboratory Immunology
|
November 1, 1987
Tumor necrosis factor enhances murine SL3-3 retrovirus replication
M J Yagi, J F Holland, J G Bekesi
Cancer Research
|
December 1, 1971
Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment
J G Bekesi, G St-Arneault, J F Holland
Blood
|
January 1, 1985
B cell differentiation
A P Efremidis, J G Bekesi, M S Vessoniaraki
Bibliotheca Haematologica
|
October 1, 1975
Chemoimmunotherapy in human and experimental leukemia
J G Bekesi, J P Roboz, J F Holland
Cellular Immunology
|
November 1, 1982
Central role of T lymphocytes in specific recognition of tumor antigens in 51Cr-leukocyte adherence inhibition
P H Tsang, J F Holland, J G Bekesi
Page
of 13